Dr. Elizabeth S. Klings, MD

Dr. Klings practices at Boston Medical Center in Boston, Massachusetts, part of Boston Medical Center Health System.

Dr. Klings' NPI, 1982681755, was assigned on December 22, 2005. Dr. Klings graduated from New York University School of Medicine in 1992. Dr. Klings holds Massachusetts license 79819.

Dr. Klings' primary practice is Boston Medical Center, at 1 Boston Medical Center Place, Boston, MA 02118 in Suffolk County. The practice phone is (617) 638-8000.

Dr. Klings' primary practice is Boston Medical Center in Boston, Massachusetts, part of Boston Medical Center Health System. The medical group on file is Boston University Medical Group (Boston University Internal Medicine Associates). Dmand AI also links Dr. Klings to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Klings practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Klings' primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Klings is licensed in Massachusetts.

CMS data shows 199 Medicare services from Dr. Klings across 2 procedure codes in 2024, for 91 Medicare patients. Medicare paid $26,879 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 91 Medicare patients who saw Dr. Klings in 2024. The largest group is 65 to 74, with 35 patients. 75% of them have high blood pressure, and 65% have high cholesterol. 71% are also on Medicaid. Their average risk score is 2.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Klings' median patient age at 58, with 62% women.

In 2024, Dr. Klings wrote 1,649 Medicare Part D claims for 110 patients. 55% of them were for generic drugs. CMS names the drug for 1,460 of them, across 34 drugs with 11 or more claims each, at $3,100,252 in total drug cost.

Dr. Klings accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 65 papers to Dr. Klings, published from 2011 to 2025. 2021 was the busiest year, with 8. The most frequent topics are Anemia, Sickle Cell, Hypertension, Pulmonary and Scleroderma, Systemic. Dr. Klings has published most often in Ann Am Thorac Soc. Dr. Klings' most frequent co-authors are Kari Gillmeyer, MD, Renda S. Wiener, MD, MPH and Justin K. Lui, MD.

Dmand AI links Dr. Klings to 8 clinical trials, 5 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Pulmonary Arterial Hypertension, Hypertension, Pulmonary and Anemia, Sickle Cell. Biogen sponsors the most, 3.

CMS Open Payments shows 23 general payments to Dr. Klings from 6 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 85% of the total. Novo Nordisk Inc paid the most, $11,216.

Dr. Klings graduated from New York University School of Medicine in 1992.